Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Clin Neurophysiol. 2017 Nov 6;129(1):210–221. doi: 10.1016/j.clinph.2017.10.024

Table 1.

Demographic and clinical characteristics of subjects.

Schizophrenia
Patients (N=12)
Controls
(N=13)
Statisticsa
Demographic variables
 Age (years) 45.3 (10.8) 46.2 (7.7) −.24
 Education (years) 13.8 (2.3) 16.8 (3.8) −2.31*
 Parental education (years) 13.7 (2.8) 12.5 (2.6) 1.04
 IQ estimate 94.9 (13.2) 113.4 (10.6) −3.98*
 % Male 83 % 76% .16

Clinical variables
 Overall symptomatologyb 44. 7 (9.4)
 Psychosis symptom scorec 1.9 (1.5)
 Negative symptom scored 1.7 (.9)
 Disorganization symptom scorese 2.3 (1.4)
 Illness duration (years) 24.8 (11.0)

Treatment variables
 Medication (CPZ equivalent) 641. 7 (445.1)

Note: Values are mean and standard deviation unless otherwise noted.

a

t(23) for continuous variables and χ2(1) for a discrete variable (i.e., % Male).

*

indicate significant group difference.

IQ was estimated using scores on the Vocabulary and Block Design Subtests of the WAIS-III.

b

Overall symptomatology score was computed as a total BPRS score (range: 24–168)

c

Psychosis symptom score was computed as the average global score for hallucinations and delusions in SAPS (range: 0 [none]-5 [severe]).

d

Negative symptom score was computed as the average global score for alogia, affective flattening, avolition-apathy, and anhedonia-asociality in SANS (range: 0 [none] - 5 [severe]).

e

Disorganization symptom score was the global score for positive formal thought disorder in SAPS (range: 0 [none] – 5 [severe]).